Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease pancreatic cancer
Phenotype C0494165|liver metastases
Sentences 14
PubMedID- 25318603 Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer.
PubMedID- 26462899 Conclusions: our data suggest that patient's bmi, time between onset and diagnosis, histological grade, and venous tumor embolus are significantly correlated with postoperative liver metastases in patients with pancreatic cancer.
PubMedID- 25962312 Identification of effective therapeutic targets is crucial for the management of pancreatic cancer patients with liver metastases.
PubMedID- 23724404 During the follow-up (1-6 years) of the remaining patients, two had further intervention for right subcostal incisional hernia and one presented non-resectable head pancreatic cancer with multiple liver metastases 1 year after cds.
PubMedID- 24634093 15-lox-1 expression is absent in lymph node and liver metastases of pancreatic cancer 14. levels of 13-s-hode, the primary product of 15-lox-1, are inversely associated with cancer cells' ability to attach to endothelial cells and metastasize in mice 16–18.
PubMedID- 21276229 So far, all animals have formed liver metastases of the injected pancreatic cancer cell lines.
PubMedID- 25614082 Our results support future investigations for pancreatic cancer patients with non-liver metastases and favorable immunological conditions.
PubMedID- 24959213 A total of 164 pancreatic cancer patients with liver metastases that were treated with chemotherapy, radiation therapy and/or qyhj were analyzed.
PubMedID- 24649263 An alternative treatment option that may be beneficial in pancreatic cancer patients with liver metastases is the hepatic arterial infusion (hai) of chemotherapeutic agents.
PubMedID- 25248901 [two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus s-1 therapy].
PubMedID- 22675973 pancreatic cancer with liver metastases in a pregnant patient: case report and review of the literature.
PubMedID- 20683216 Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or chinese herbal medicine.
PubMedID- 24130758 Overall median survival time was 4.7 months and 1-year overall survival rate was 14% for pancreatic cancer with liver metastases [11].
PubMedID- 23205084 The increased levels of plasma mir-21, mir-25, mir-103 and mir-151, as well as the identification of cd133(+)ck18(+) cells in the pleural fluid of a pancreatic cancer patient with liver metastases, may regulate the molecular mechanisms involved in chemoresistance.

Page: 1